Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 3Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 19Leukemia 16Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Congenital Abnormalities 3Sarcoma, Ewing 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Sarcoma 1Recurrence 1

Interventions

Cytarabine 18Daunorubicin 13Etoposide 12Filgrastim 8Mitoxantrone 7Peripheral Blood Stem Cell Transplantation 6Idarubicin 6Radiotherapy 4Observation 4Gemtuzumab 4Cyclophosphamide 4valspodar 3aldesleukin 3Tretinoin 3Busulfan 3sargramostim 2Watchful Waiting 2Thioguanine 2Granulocyte Colony-Stimulating Factor 2Amsacrine 2zosuquidar trihydrochloride 1tipifarnib 1midostaurin 1lintuzumab 1laromustine 1fludarabine phosphate 1flt3 ligand protein 1etoposide phosphate 1dexamethasone acetate 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Monocytic, Acute × Busulfan × Clear all
NCT00006363 2013-06-04

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
720 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00002549 2009-12-23

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
1,520 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00004128 2009-12-23

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡